6wgl
From Proteopedia
(Difference between revisions)
m (Protected "6wgl" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 6wgl is ON HOLD | + | The entry 6wgl is ON HOLD until Paper Publication |
Authors: Druzina, Z., Atwell, S., Pustilnik, A., Antonysamy, S., Ho, C., Lieu, R., Hendle, J., Benach, J., Wang, J. | Authors: Druzina, Z., Atwell, S., Pustilnik, A., Antonysamy, S., Ho, C., Lieu, R., Hendle, J., Benach, J., Wang, J. | ||
| - | Description: Dupilumab | + | Description: Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor |
[[Category: Unreleased Structures]] | [[Category: Unreleased Structures]] | ||
[[Category: Hendle, J]] | [[Category: Hendle, J]] | ||
Revision as of 04:14, 22 April 2020
Unreleased structure
The entry 6wgl is ON HOLD until Paper Publication
Authors: Druzina, Z., Atwell, S., Pustilnik, A., Antonysamy, S., Ho, C., Lieu, R., Hendle, J., Benach, J., Wang, J.
Description: Dupilumab fab with Crystal Kappa design complexed with human IL-4 receptor
Categories: Unreleased Structures | Hendle, J | Ho, C | Druzina, Z | Benach, J | Atwell, S | Antonysamy, S | Wang, J | Lieu, R | Pustilnik, A
